Cargando…
Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages
Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...
Autores principales: | Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342066/ https://www.ncbi.nlm.nih.gov/pubmed/27764779 http://dx.doi.org/10.18632/oncotarget.12737 |
Ejemplares similares
-
Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment
por: Yu, Yang, et al.
Publicado: (2016) -
Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion
por: Yu, Yang, et al.
Publicado: (2018) -
The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner
por: Cheng, Jiwen, et al.
Publicado: (2016) -
Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
por: Hao, Chong, et al.
Publicado: (2014) -
Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells
por: Wang, Yadong, et al.
Publicado: (2017)